Literature DB >> 9674126

The expression of the protective antigen of Bacillus anthracis in Bacillus subtilis.

L Baillie1, A Moir, R Manchee.   

Abstract

The expression of Bacillus anthracis protective antigen (PA) in B. subtilis from the pag gene in pPA101-1 was explored in different genetic backgrounds in an attempt to identify opportunities to maximize expression. Introduction of AtxA, which positively regulates PA expression in B. anthracis did not improve expression levels in the protease-deficient strain WB600. Plasmid pPA101-1 was found to carry a deletion which created a new fusion point between vector and insert sequence, and which removed part of the AtxA binding site. The deletion may have occurred as a consequence of recombination between TCTAT sequences within both the vector and insert. Host mutations could influence expression; PA levels from pPA101-1 are threefold higher in a ccpA mutant than in an otherwise isogenic parent, and eightfold higher in an abrB mutant. These data demonstrate that the introduction of mutations affecting catabolite repression and growth phase regulation results in an increase in the yield of PA in this host-vector system. Combining these mutations with a multiply protease-negative background could potentially allow further improvements in PA yield.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674126     DOI: 10.1046/j.1365-2672.1998.00405.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  15 in total

1.  Control of anthrax toxin gene expression by the transition state regulator abrB.

Authors:  Elke Saile; Theresa M Koehler
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

2.  Progress toward the Development of a NEAT Protein Vaccine for Anthrax Disease.

Authors:  Miriam A Balderas; Chinh T Q Nguyen; Austen Terwilliger; Wendy A Keitel; Angelina Iniguez; Rodrigo Torres; Frederico Palacios; Celia W Goulding; Anthony W Maresso
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

3.  In vitro and in vivo activities of recombinant anthrax protective antigen co-expressed with thioredoxin in Escherichia coli.

Authors:  Yao Ma; Yun-Zhou Yu; Yu-Feng Zhu; Qing Xu; Zhi-Wei Sun
Journal:  Hum Vaccin Immunother       Date:  2013-07-23       Impact factor: 3.452

4.  The alternative sigma factor sigmaH is required for toxin gene expression by Bacillus anthracis.

Authors:  Maria Hadjifrangiskou; Yahua Chen; Theresa M Koehler
Journal:  J Bacteriol       Date:  2006-12-22       Impact factor: 3.490

5.  Characterization of sporulation histidine kinases of Bacillus anthracis.

Authors:  Ryan L Brunsing; Chandra La Clair; Sharon Tang; Christina Chiang; Lynn E Hancock; Marta Perego; James A Hoch
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

6.  Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax.

Authors:  S Cohen; I Mendelson; Z Altboum; D Kobiler; E Elhanany; T Bino; M Leitner; I Inbar; H Rosenberg; Y Gozes; R Barak; M Fisher; C Kronman; B Velan; A Shafferman
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

7.  Sensor domains encoded in Bacillus anthracis virulence plasmids prevent sporulation by hijacking a sporulation sensor histidine kinase.

Authors:  Andrea K White; James A Hoch; Marcin Grynberg; Adam Godzik; Marta Perego
Journal:  J Bacteriol       Date:  2006-09       Impact factor: 3.490

8.  Optimization of the cell wall microenvironment allows increased production of recombinant Bacillus anthracis protective antigen from B. subtilis.

Authors:  Joanne E Thwaite; Les W J Baillie; Noel M Carter; Keith Stephenson; Mark Rees; Colin R Harwood; Peter T Emmerson
Journal:  Appl Environ Microbiol       Date:  2002-01       Impact factor: 4.792

9.  Cloning, expression and purification of binding domains of lethal factor and protective antigen of Bacillus anthracis in Escherichia coli and evaluation of their related murine antibody.

Authors:  Mehdi Rezaee; Hossein Honari; Mohammad Reza Ashrafi Kooshk
Journal:  Mol Biol Rep       Date:  2014-01-16       Impact factor: 2.316

10.  Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines.

Authors:  O Gat; I Inbar; R Aloni-Grinstein; E Zahavy; C Kronman; I Mendelson; S Cohen; B Velan; A Shafferman
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.